학술논문
Neutrophil‐to‐Lymphocyte Ratios in Patients Undergoing Aortic Valve Replacement: The PARTNER Trials and Registries
Document Type
article
Author
Shahim, Bahira; Redfors, Björn; Lindman, Brian R; Chen, Shmuel; Dahlen, Torsten; Nazif, Tamim; Kapadia, Samir; Gertz, Zachary M; Crowley, Aaron C; Li, Ditian; Thourani, Vinod H; Kodali, Susheel K; Zajarias, Alan; Babaliaros, Vasilis C; Guyton, Robert A; Elmariah, Sammy; Herrmann, Howard C; Cohen, David J; Mack, Michael J; Smith, Craig R; Leon, Martin B; George, Isaac
Source
Journal of the American Heart Association. 11(11)
Subject
Language
Abstract
Background The neutrophil-to-lymphocyte ratio (NLR) as a marker of systemic inflammation has been associated with worse prognosis in several chronic disease states, including heart failure. However, few data exist on the prognostic impact of elevated baseline NLR or change in NLR levels during follow-up in patients undergoing transcatheter or surgical aortic valve replacement (TAVR or SAVR) for aortic stenosis. Methods and Results NLR was available in 5881 patients with severe aortic stenosis receiving TAVR or SAVR in PARTNER (Placement of Aortic Transcatheter Valves) I, II, and S3 trials/registries (median [Q1, Q3] NLR, 3.30 [2.40, 4.90]); mean NLR, 4.10; range, 0.5-24.9) and was evaluated as continuous variable and categorical tertiles (low: NLR ≤2.70, n=1963; intermediate: NLR 2.70-4.20, n=1958; high: NLR ≥4.20, n=1960). No patients had known baseline infection. High baseline NLR was associated with increased risk of death or rehospitalization at 3 years (58.4% versus 41.0%; adjusted hazard ratio [aHR], 1.39; 95% CI, 1.18-1.63; P